GUARDANT HEALTH (Germany) Investor Sentiment

5GH Stock  EUR 37.42  1.38  3.56%   
Roughly 61% of GUARDANT HEALTH's investor base is looking to short. The analysis of current outlook of investing in GUARDANT HEALTH CL suggests that many traders are alarmed regarding GUARDANT HEALTH's prospects. The current market sentiment, together with GUARDANT HEALTH's historical and current headlines, can help investors time the market. In addition, many technical investors use GUARDANT HEALTH CL stock news signals to limit their universe of possible portfolio assets.
GUARDANT HEALTH stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of GUARDANT daily returns and investor perception about the current price of GUARDANT HEALTH CL as well as its diversification or hedging effects on your existing portfolios.
  
over three months ago at news.google.com         
Stocks Showing Improving Market Leadership Charles Schwab Earns 81 RS Rating - Inkl
Google News at Macroaxis
over three months ago at news.google.com         
Cathie Wood Goes Bargain Hunting 3 Stocks She Just Bought - AOL
Google News at Macroaxis
over three months ago at news.google.com         
Assured Guaranty Shows Rising Relative Price Performance Still Shy Of Key Benchmark - MSN
Google News at Macroaxis
over three months ago at news.google.com         
Guardant Health Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Guardant Health Pops 13 percent On An Impressive Beat Following Exact Sciences Flop - Yahoo Voices
Google News at Macroaxis
over six months ago at news.google.com         
The battle brewing over blood tests for cancer Today News - Mint
Google News at Macroaxis
over six months ago at news.google.com         
TD Asset Management Inc Decreases Stake in Guardant Health, Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Liquidia Technologies Soars 14.1 percent Is Further Upside Left in the Stock - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Midday movers PDD Holdings, NVIDIA fall Xpeng gains - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
Guardant Health Sees RS Rating Climb To 72 - Investors Business Daily
Google News at Macroaxis
over six months ago at news.google.com         
The Benefits and Risks of Using Liquid Biopsy for CRC Screening - AJMC.com Managed Markets Network
Google News at Macroaxis
over six months ago at news.google.com         
FDA to inspect med stocks at doctors clinics - The Times of India
Google News at Macroaxis
over six months ago at news.google.com         
FDA approves Guardant Healths blood test for colon cancer - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test, Fur...
Google News at Macroaxis
over six months ago at news.google.com         
Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors - StockTitan
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about GUARDANT HEALTH that are available to investors today. That information is available publicly through GUARDANT media outlets and privately through word of mouth or via GUARDANT internal channels. However, regardless of the origin, that massive amount of GUARDANT data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of GUARDANT HEALTH news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of GUARDANT HEALTH relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to GUARDANT HEALTH's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive GUARDANT HEALTH alpha.

GUARDANT HEALTH Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for GUARDANT Stock analysis

When running GUARDANT HEALTH's price analysis, check to measure GUARDANT HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GUARDANT HEALTH is operating at the current time. Most of GUARDANT HEALTH's value examination focuses on studying past and present price action to predict the probability of GUARDANT HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GUARDANT HEALTH's price. Additionally, you may evaluate how the addition of GUARDANT HEALTH to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Directory
Find actively traded commodities issued by global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account